Differential effects of vildagliptin and glimepiride on glucose fluctuations in patients with type 2 diabetes mellitus assessed using continuous glucose monitoring-Reference-Cited by-同舟云学术

Differential effects of vildagliptin and glimepiride on glucose fluctuations in patients with type 2 diabetes mellitus assessed using continuous glucose monitoring

Published:2013-07-14 Issue:12 Volume:15 Page:1111-1119
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

He Y. L.¹,Foteinos G.¹,Neelakantham S.²,Mattapalli D.²,Kulmatycki K.¹,Forst T.³,Taylor A.¹

Affiliation:

1. Translational Medicine; Novartis Institutes for Biomedical Research, Novartis; Cambridge MA USA

2. Integrated Information Sciences, Novartis Institutes for Biomedical Research, Novartis; Hyderabad India

3. Institute for Clinical Research and Development; Mainz Germany

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12146/fullpdf

Reference39 articles.

1. Hyperglycemia and microvascular and macrovascular disease in diabetes;Klein;Diabetes Care,1995

2. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial;The Diabetes Control and Complications Trial Research Group;Diabetes,1995

3. Epidemiology of macrovascular disease in diabetes;Laakso;Diabetes Rev,1997

4. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study;Stratton;BMJ,2000

5. Postprandial hyperglycemia and diabetes complications: is it time to treat?;Ceriello;Diabetes,2005

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review on the clinical pharmacokinetics of vildagliptin in healthy and disease populations;Expert Opinion on Drug Metabolism & Toxicology;2023-11-26

2. Influence of dipeptidyl peptidase-4 inhibitors on glycemic variability in patients with type 2 diabetes: A meta-analysis of randomized controlled trials;Frontiers in Endocrinology;2022-08-09

3. Sodium–glucose cotransporter 2 inhibitors reduce day‐to‐day glucose variability in patients with type 1 diabetes;Journal of Diabetes Investigation;2020-08-02

4. Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus;Journal of Diabetes Investigation;2020-03-27

5. A safety and tolerability profile comparison between dipeptidyl peptidase-4 inhibitors and sulfonylureas in diabetic patients: A systematic review and meta-analysis;Diabetes Research and Clinical Practice;2019-03